KPV
α-MSH C-Terminal Tripeptide
Lysine-proline-valine — the C-terminal tripeptide of α-MSH studied for anti-inflammatory and gut-barrier endpoints. Available in 5 mg and 10 mg.
Recovery & Healing
Category
From $53.99
Price
Research
Grade
Price
From $53.99
✓ 10% off via PeptidesMuscle
Suggested Protocol
Same as the 10mg size: 250–500mcg subcutaneously daily or equivalent oral/rectal dose. A 5mg vial covers 20 days at 250mcg/day or 10 days at 500mcg/day, making it well-matched to 2–3 week pilot cycles. Reconstituted solution remains stable 28 days refrigerated.
KPV is the lysine-proline-valine tripeptide fragment of alpha-melanocyte stimulating hormone, carrying alpha-MSH's anti-inflammatory signalling while eliminating the pigmentation-driving receptor binding in the parent molecule. The 5mg presentation is functionally identical to the 10mg — same compound, same purity — but sized for shorter or lower-dose research.
Size Rationale
Why a Smaller Vial Has a Specific Role
Reconstituted peptide in bacteriostatic water is stable for 28 days refrigerated. For researchers running a two-week pilot or an intermittent acute-flare protocol, a 10mg vial would exceed that window before being consumed, meaning peptide is discarded. The 5mg size maps the vial quantity to the protocol length so nothing is wasted.
Equivalent Chemistry
What Is and Is Not Different
The peptide is identical: same tripeptide, same synthesis route, same certificate of analysis specifications as the 10mg presentation. The only differences are total peptide quantity and price-per-mg (the 5mg runs slightly higher per mg to cover per-unit packaging costs). Mechanism, dosing, and protocol apply identically.
When to Upgrade
Signals That Point to the 10mg Vial
Once a researcher has validated their KPV protocol and moves to ongoing multi-month research, the per-mg cost advantage of the 10mg size typically outweighs the smaller vial's stability benefit. Most KPV users switch to the larger size after their first one or two 5mg cycles, reserving 5mg vials for occasional acute-flare work.
Reported Outcomes
Same compound and purity as the 10mg vial — just smaller total quantity
Right-sized for 14-day pilot studies or first-time KPV research protocols
20 days of coverage at standard 250mcg research dose — fits within single reconstitution stability window
Avoids wasting peptide on short-duration protocols where a 10mg vial would expire unused
Lower entry cost for researchers validating tolerability before committing
Same oral, rectal, and subcutaneous administration options as the larger vial
Specifications
| Product | KPV |
|---|---|
| Category | Recovery & Healing |
| Format | Lyophilized powder |
| Price | From $53.99 |
Pairs Well With
Ready to start?
From $53.99
✓ 10% off via PeptidesMuscle
Administration Outline
Same as the 10mg size: 250–500mcg subcutaneously daily or equivalent oral/rectal dose. A 5mg vial covers 20 days at 250mcg/day or 10 days at 500mcg/day, making it well-matched to 2–3 week pilot cycles. Reconstituted solution remains stable 28 days refrigerated.
KPV — FAQs
More in Recovery & Healing
View All
VIP (Vasoactive Intestinal Peptide)
Vasoactive intestinal peptide — 28-residue neuropeptide studied for smooth-muscle relaxation and mast-cell stabilization research. Available in 5 mg and 10 mg.
Cardiogen 20mg
Cardiogen — the myocardial entry in Khavinson's bioregulator series — is a short peptide (commonly written as Ala-Glu-Asp-Arg) extracted from work on calf cardiac tissue and taken as a synthetic successor to the heart-derived drug Kardiolin.
Pancragen 20mg
Pancragen is the Khavinson series' pancreatic bioregulator — a Lys-Glu-Asp-Trp (KEDW) tetrapeptide positioned for research on islet and exocrine pancreatic cells in ageing, paired canonically with Livagen for the hepatic/pancreatic metabolic axis.
